Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefano Partelli

Showing results (241-250 of 281) with videos related to

Pageof 29
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|October 7, 2025
AIMN, ITANET, SIE joint position paper for the recognition, prevention and management of NET carcinoid syndrome and crises during peptide receptor radionuclide therapyRiccardo Laudicella, Antongiulio Faggiano, Valeria Pirro, et al.
ESMO Open|November 14, 2020
Bratislava Statement: consensus recommendations for improving pancreatic cancer careJoan Prades, Dirk Arnold, Thomas Brunner, et al.
The American Journal of Surgical Pathology|March 27, 2019
Neuroendocrine Tumors (NETs) of the Minor Papilla/Ampulla: Analysis of 16 Cases Underlines Homology With Major Ampulla NETs and Differences From Extra-Ampullary Duodenal NETsAlessandro Vanoli, Luca Albarello, Stefania Uncini, et al.
World Journal of Urology|July 29, 2022
Pancreatic metastases after surgery for renal cell carcinoma: survival and pathways of progressionDaniele Cignoli, Giuseppe Fallara, Francesca Aleotti, et al.
Annals of Surgery|July 9, 2019
A Novel Validated Recurrence Risk Score to Guide a Pragmatic Surveillance Strategy After Resection of Pancreatic Neuroendocrine Tumors: An International Study of 1006 PatientsMohammad Y Zaidi, Alexandra G Lopez-Aguiar, Jeffrey M Switchenko, et al.
Annals of Surgical Oncology|December 5, 2014
Surgical resection does not improve survival in patients with renal metastases to the pancreas in the era of tyrosine kinase inhibitorsMatteo Santoni, Alessandro Conti, Stefano Partelli, et al.
Cancer Treatment Reviews|July 9, 2021
European Cancer Organisation Essential Requirements for Quality Cancer Care (ERQCC): Pancreatic CancerStefano Partelli, Francesco Sclafani, Sorin Traian Barbu, et al.
Asian Journal of Urology|November 16, 2022
Multidisciplinary management of patients diagnosed with von Hippel-Lindau disease: A practical review of the literature for cliniciansAlessandro Larcher, Federico Belladelli, Giuseppe Fallara, et al.
Cell Genomics|July 3, 2024
Implications of noncoding regulatory functions in the development of insulinomasMireia Ramos-Rodríguez, Marc Subirana-Granés, Richard Norris, et al.
The Lancet Regional Health. Europe|April 22, 2026
Real-world presentation and outcomes of gastroenteropancreatic neuroendocrine neoplasms in Italy: findings from the nationwide Itanet prospective databaseFrancesco Panzuto, Maria Rinzivillo, Stefano Partelli, et al.
Pageof 29

Showing results (241-250 of 281) with videos related to

Sort By:
Pageof 29
European Journal of Nuclear Medicine and Molecular Imaging|October 7, 2025
AIMN, ITANET, SIE joint position paper for the recognition, prevention and management of NET carcinoid syndrome and crises during peptide receptor radionuclide therapyRiccardo Laudicella, Antongiulio Faggiano, Valeria Pirro, et al.
ESMO Open|November 14, 2020
Bratislava Statement: consensus recommendations for improving pancreatic cancer careJoan Prades, Dirk Arnold, Thomas Brunner, et al.
The American Journal of Surgical Pathology|March 27, 2019
Neuroendocrine Tumors (NETs) of the Minor Papilla/Ampulla: Analysis of 16 Cases Underlines Homology With Major Ampulla NETs and Differences From Extra-Ampullary Duodenal NETsAlessandro Vanoli, Luca Albarello, Stefania Uncini, et al.
World Journal of Urology|July 29, 2022
Pancreatic metastases after surgery for renal cell carcinoma: survival and pathways of progressionDaniele Cignoli, Giuseppe Fallara, Francesca Aleotti, et al.
Annals of Surgery|July 9, 2019
A Novel Validated Recurrence Risk Score to Guide a Pragmatic Surveillance Strategy After Resection of Pancreatic Neuroendocrine Tumors: An International Study of 1006 PatientsMohammad Y Zaidi, Alexandra G Lopez-Aguiar, Jeffrey M Switchenko, et al.
Annals of Surgical Oncology|December 5, 2014
Surgical resection does not improve survival in patients with renal metastases to the pancreas in the era of tyrosine kinase inhibitorsMatteo Santoni, Alessandro Conti, Stefano Partelli, et al.
Cancer Treatment Reviews|July 9, 2021
European Cancer Organisation Essential Requirements for Quality Cancer Care (ERQCC): Pancreatic CancerStefano Partelli, Francesco Sclafani, Sorin Traian Barbu, et al.
Asian Journal of Urology|November 16, 2022
Multidisciplinary management of patients diagnosed with von Hippel-Lindau disease: A practical review of the literature for cliniciansAlessandro Larcher, Federico Belladelli, Giuseppe Fallara, et al.
Cell Genomics|July 3, 2024
Implications of noncoding regulatory functions in the development of insulinomasMireia Ramos-Rodríguez, Marc Subirana-Granés, Richard Norris, et al.
The Lancet Regional Health. Europe|April 22, 2026
Real-world presentation and outcomes of gastroenteropancreatic neuroendocrine neoplasms in Italy: findings from the nationwide Itanet prospective databaseFrancesco Panzuto, Maria Rinzivillo, Stefano Partelli, et al.
Pageof 29